Incyte (INCY) Income from Continuing Operations (2010 - 2026)

Incyte (INCY) reported Income from Continuing Operations of 303330000.0 for Q1 2026, up 91.73% on a YoY basis from 158203000.0 in Q1 2025, and up 1.35% quarter-over-quarter from 299279000.0 in Q4 2025.

Incyte (INCY) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Incyte has reported Income from Continuing Operations for 17 years, with the latest figure at 303330000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations rose 91.73% year-over-year to 303330000.0; the trailing twelve-month figure through Mar 2026 stood at 1431777000.0 (up 6631.44% YoY), and the FY2025 full-year result was 1286650000.0, up 3844.96% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 303330000.0, up from 299279000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 424169000.0 in Q3 2025, with the low at 444601000.0 in Q2 2024.
  • Historically, Income from Continuing Operations has averaged 150638470.59 across 5 years, with a median of 169548000.0 in 2024.
  • The largest YoY upside for Income from Continuing Operations was 681.22% in 2024 against a maximum downside of 318.43% in 2024.
  • Incyte's Income from Continuing Operations stood at 28461000.0 in 2022, then jumped by 606.51% to 201079000.0 in 2023, then climbed by 0.07% to 201212000.0 in 2024, then surged by 48.74% to 299279000.0 in 2025, then grew by 1.35% to 303330000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 303330000.0 (Q1 2026), 299279000.0 (Q4 2025), and 424169000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 303.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 303.33 Mn
Dec 31, 2025 299.28 Mn
Sep 30, 2025 424.17 Mn
Jun 30, 2025 405.00 Mn
Mar 31, 2025 158.20 Mn
Dec 31, 2024 201.21 Mn
Sep 30, 2024 106.46 Mn
Jun 30, 2024 -444.60 Mn
Mar 31, 2024 169.55 Mn
Dec 31, 2023 201.08 Mn
Sep 30, 2023 171.27 Mn
Jun 30, 2023 203.55 Mn
Mar 31, 2023 21.70 Mn
Dec 31, 2022 28.46 Mn
Sep 30, 2022 112.78 Mn
Jun 30, 2022 161.43 Mn
Mar 31, 2022 37.99 Mn
Dec 31, 2021 563.85 Mn
Sep 30, 2021 181.77 Mn
Jun 30, 2021 149.46 Mn